SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-023611
Filing Date
2024-03-19
Accepted
2024-03-18 17:42:18
Documents
72
Period of Report
2024-01-31

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0200890-6k_clear.htm   iXBRL 6-K 17861
2 CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS FOR THE THREE MONTHS ENDED J ea0200890ex99-1_clear.htm   iXBRL EX-99.1 515158
3 MANAGEMENT'S DISCUSSION AND ANALYSIS FOR THE FOR THE THREE MONTHS ENDED JANUARY ea0200890ex99-2_clear.htm EX-99.2 152486
  Complete submission text file 0001213900-24-023611.txt   4210761

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE cmnd-20240131.xsd EX-101.SCH 84646
5 XBRL CALCULATION FILE cmnd-20240131_cal.xml EX-101.CAL 28700
6 XBRL DEFINITION FILE cmnd-20240131_def.xml EX-101.DEF 237520
7 XBRL LABEL FILE cmnd-20240131_lab.xml EX-101.LAB 472582
8 XBRL PRESENTATION FILE cmnd-20240131_pre.xml EX-101.PRE 249247
76 EXTRACTED XBRL INSTANCE DOCUMENT ea0200890-6k_clear_htm.xml XML 536949
Mailing Address 101-1220 WEST 6TH AVENUE VANCOUVER, BRITISH COLUMBIA Z4 V6H1A5
Business Address 101-1220 WEST 6TH AVENUE VANCOUVER, BRITISH COLUMBIA Z4 V6H1A5 972-54-5704749
Clearmind Medicine Inc. (Filer) CIK: 0001892500 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: 6-K | Act: 34 | File No.: 001-41557 | Film No.: 24760316
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)